← SynDRA
FLUPHENAZINE DECANOATE
SynDRA canonical compound SYN0023237 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | DRD2 | HTR1B | HTR4 |
|---|
| Mechanism of action | dopamine receptor antagonist |
|---|
| Indication | schizophrenia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- DRD2
- HTR1B
- HTR4
- DRD1
- HTR2A
- HTR6
- HTR7
- DRD5
- HRH1
- CALM1
- CHRNA7
- OPRM1
Mechanisms of action (all sources)
- DRD2 ANTAGONIST
- Dopamine D2 receptor antagonist
- dopamine receptor antagonist
- HTR1B MODULATOR
- HTR2A ANTAGONIST
- HTR6 INVERSE AGONIST
- HTR7 INVERSE AGONIST
- DRD1 ANTAGONIST
- DRD5 ANTAGONIST
- HRH1 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Drug classes
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Psychotropic Drugs
- Tranquilizing Agents
- Dopamine Agents
- Dopamine Antagonists
- Neurotransmitter Agents
- Phenothiazine
ATC classes
Cross-references
Synonyms
- PROLIXIN DECANOATE
- flufenazine decanoate
- fluorophenazine decanoate
- lyogen
- modecate
- prolixin decanoate
- Dapotum d
- Fluphenazini decanoas
- Lyogen
- Moditen depot
- NSC-169510
- QD-10733
- SQ-10733
- Decazate
- Depot
- Modecate
- Modecate conc
- Prolixin decanoate
- Dapotum D
- Flufenazine decanoate
- Fluorophenazine decanoate
- Fluphenaline decanoate
- Fluphenazine depot
- Fluphenazine O-decanoate
- Moditen-depo
- Prolixin decanoate (TN)
- SQ 10,733
- Fluphenazine decanoate (JAN/USP)
- moditen-depot
- fluphenazine enanthate impurity c (ep impurity)
- FMU62K1L3C
- NSC 169510
- fluphenazine decanoate (usp impurity)
- fluphenazine decanoate (ep monograph)
- fluphenazine decanoate (usp monograph)
- DEPOT
Reported adverse events
- Dyskinesia
- Hypotension
- Skin disorder
- Dystonia
- Hypertension
- Muscle rigidity
- Leukocytosis
Look up FLUPHENAZINE DECANOATE in the interactive SynDRA portal →